Prevalence of Hyperemesis Gravidarum

Launched by UNIVERSITY HOSPITAL, CLERMONT-FERRAND · May 14, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a condition called hyperemesis gravidarum (HG), which is a severe form of nausea and vomiting that can occur during pregnancy. While many women experience mild nausea during their first trimester that usually goes away, some women suffer from HG, which can be very debilitating and may require hospitalization. The goal of this study is to understand how common both mild and severe nausea and vomiting are during pregnancy, particularly in the first trimester, and to learn more about how these symptoms affect women's daily lives and overall health.

To participate in this study, women must be pregnant, living in the Auvergne region of France, and able to speak French. They also need to be receiving regular medical care for their pregnancy and agree to take part in the research. The study will ask participants about their experiences with nausea and vomiting, and how it impacts their quality of life throughout their pregnancy. This information is important because it can help raise awareness about HG and improve the support available for women who experience this condition.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Women having a monitored pregnancy in Auvergne,
• • Major,
• • Speaking French,
• • Socially insured,
• • Having given their agreement to participate in the study.
• Exclusion Criteria:
• • Women refusing to participate in the study,
• • Not speaking French,
• • Major incapacitated persons.